Cipher Pharmaceuticals Statistics
Total Valuation
TSX:CPH has a market cap or net worth of CAD 363.94 million. The enterprise value is 351.53 million.
| Market Cap | 363.94M |
| Enterprise Value | 351.53M |
Important Dates
The last earnings date was Wednesday, August 12, 2026.
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TSX:CPH has 25.42 million shares outstanding. The number of shares has decreased by -1.02% in one year.
| Current Share Class | 25.42M |
| Shares Outstanding | 25.42M |
| Shares Change (YoY) | -1.02% |
| Shares Change (QoQ) | +0.71% |
| Owned by Insiders (%) | 3.95% |
| Owned by Institutions (%) | 1.50% |
| Float | 14.84M |
Valuation Ratios
The trailing PE ratio is 8.98 and the forward PE ratio is 12.11.
| PE Ratio | 8.98 |
| Forward PE | 12.11 |
| PS Ratio | 5.16 |
| PB Ratio | 1.87 |
| P/TBV Ratio | 5.08 |
| P/FCF Ratio | 9.49 |
| P/OCF Ratio | 9.47 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.25, with an EV/FCF ratio of 9.16.
| EV / Earnings | 8.54 |
| EV / Sales | 4.99 |
| EV / EBITDA | 9.25 |
| EV / EBIT | 12.55 |
| EV / FCF | 9.16 |
Financial Position
The company has a current ratio of 1.59, with a Debt / Equity ratio of 0.00.
| Current Ratio | 1.59 |
| Quick Ratio | 1.09 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | 0.01 |
| Interest Coverage | 51.11 |
Financial Efficiency
Return on equity (ROE) is 23.50% and return on invested capital (ROIC) is 15.46%.
| Return on Equity (ROE) | 23.50% |
| Return on Assets (ROA) | 7.97% |
| Return on Invested Capital (ROIC) | 15.46% |
| Return on Capital Employed (ROCE) | 14.36% |
| Weighted Average Cost of Capital (WACC) | 6.87% |
| Revenue Per Employee | 14.09M |
| Profits Per Employee | 8.23M |
| Employee Count | 5 |
| Asset Turnover | 0.32 |
| Inventory Turnover | 1.25 |
Taxes
| Income Tax | -16.37M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +0.42% in the last 52 weeks. The beta is 0.46, so TSX:CPH's price volatility has been lower than the market average.
| Beta (5Y) | 0.46 |
| 52-Week Price Change | +0.42% |
| 50-Day Moving Average | 16.33 |
| 200-Day Moving Average | 15.98 |
| Relative Strength Index (RSI) | 32.53 |
| Average Volume (20 Days) | 60,717 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TSX:CPH had revenue of CAD 70.47 million and earned 41.17 million in profits. Earnings per share was 1.59.
| Revenue | 70.47M |
| Gross Profit | 57.36M |
| Operating Income | 28.02M |
| Pretax Income | 24.80M |
| Net Income | 41.17M |
| EBITDA | 37.60M |
| EBIT | 28.02M |
| Earnings Per Share (EPS) | 1.59 |
Balance Sheet
The company has 12.94 million in cash and 521,177 in debt, with a net cash position of 12.42 million or 0.49 per share.
| Cash & Cash Equivalents | 12.94M |
| Total Debt | 521,177 |
| Net Cash | 12.42M |
| Net Cash Per Share | 0.49 |
| Equity (Book Value) | 194.91M |
| Book Value Per Share | 7.67 |
| Working Capital | 16.29M |
Cash Flow
In the last 12 months, operating cash flow was 38.43 million and capital expenditures -61,064, giving a free cash flow of 38.36 million.
| Operating Cash Flow | 38.43M |
| Capital Expenditures | -61,064 |
| Depreciation & Amortization | 9.30M |
| Net Borrowing | -34.88M |
| Free Cash Flow | 38.36M |
| FCF Per Share | 1.51 |
Margins
Gross margin is 81.40%, with operating and profit margins of 39.76% and 58.42%.
| Gross Margin | 81.40% |
| Operating Margin | 39.76% |
| Pretax Margin | 35.19% |
| Profit Margin | 58.42% |
| EBITDA Margin | 53.36% |
| EBIT Margin | 39.76% |
| FCF Margin | 56.10% |
Dividends & Yields
TSX:CPH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.02% |
| Shareholder Yield | 1.02% |
| Earnings Yield | 11.31% |
| FCF Yield | 10.54% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for TSX:CPH is 19.95, which is 39.32% higher than the current price. The consensus rating is "Buy".
| Price Target | 19.95 |
| Price Target Difference | 39.32% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 8.47% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TSX:CPH has an Altman Z-Score of 10.46 and a Piotroski F-Score of 4.
| Altman Z-Score | 10.46 |
| Piotroski F-Score | 4 |